BSE Live
Nov 11, 16:01Prev. Close
405.50
Open Price
405.05
Bid Price (Qty.)
395.00 (10)
Offer Price (Qty.)
424.95 (1)
NSE Live
Nov 11, 15:51Prev. Close
405.85
Open Price
405.85
Bid Price (Qty.)
396.65 (55)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Panacea Biotec (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | -10.65 | -0.07 | -37.57 | -33.92 | 21.35 | |
| Diluted EPS (Rs.) | -10.65 | -0.07 | -37.57 | -33.92 | 21.35 | |
| Cash EPS (Rs.) | 0.08 | 11.15 | -23.91 | -21.60 | 33.96 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 85.38 | 91.73 | 91.56 | 132.47 | 103.88 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 85.38 | 91.73 | 91.56 | 132.47 | 103.88 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.75 | |
| Revenue from Operations/Share (Rs.) | 110.80 | 82.06 | 97.21 | 114.29 | 187.57 | |
| PBDIT/Share (Rs.) | 15.59 | -13.15 | -12.83 | -14.10 | 46.39 | |
| PBIT/Share (Rs.) | 4.87 | -24.37 | -26.46 | -26.40 | 34.46 | |
| PBT/Share (Rs.) | -10.33 | -0.07 | -40.89 | -42.90 | 25.37 | |
| Net Profit/Share (Rs.) | -10.64 | -0.07 | -37.54 | -33.90 | 22.03 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 14.07 | -16.02 | -13.19 | -12.33 | 24.72 | |
| PBIT Margin (%) | 4.39 | -29.69 | -27.21 | -23.10 | 18.37 | |
| PBT Margin (%) | -9.32 | -0.08 | -42.05 | -37.53 | 13.52 | |
| Net Profit Margin (%) | -9.60 | -0.08 | -38.61 | -29.65 | 11.74 | |
| Return on Networth / Equity (%) | -12.46 | -0.07 | -41.00 | -25.58 | 21.20 | |
| Return on Capital Employed (%) | 2.52 | -14.27 | -13.82 | -12.26 | 18.55 | |
| Return on Assets (%) | -3.47 | -0.02 | -13.69 | -11.21 | 7.86 | |
| Total Debt/Equity (X) | 1.81 | 1.48 | 1.61 | 0.93 | 1.27 | |
| Asset Turnover Ratio (%) | 36.14 | 26.66 | 35.47 | 37.81 | 66.93 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 0.45 | 0.36 | 0.64 | 0.87 | 1.26 | |
| Quick Ratio (X) | 0.25 | 0.15 | 0.20 | 0.23 | 0.62 | |
| Inventory Turnover Ratio (X) | 4.82 | 2.85 | 2.65 | 2.06 | 3.12 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 3.39 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 2.20 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 96.61 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 97.80 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 1,781.01 | 1,406.59 | 1,659.08 | 1,241.86 | 1,882.44 | |
| EV/Net Operating Revenue (X) | 2.62 | 2.80 | 2.78 | 1.77 | 1.64 | |
| EV/EBITDA (X) | 18.64 | -17.45 | -21.09 | -14.37 | 6.62 | |
| MarketCap/Net Operating Revenue (X) | 1.26 | 1.16 | 1.28 | 0.71 | 0.97 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 96.60 | |
| Price/BV (X) | 1.64 | 1.03 | 1.36 | 0.62 | 1.75 | |
| Price/Net Operating Revenue | 1.26 | 1.16 | 1.28 | 0.71 | 0.97 | |
| Earnings Yield | -0.08 | 0.00 | -0.30 | -0.41 | 0.12 |
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
03.06.2025
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y
24.04.2025
04.03.2025
Panacea Biotec Consolidated December 2024 Net Sales at Rs 163.49 crore, up 8.63% Y-o-Y
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
03.06.2025
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y
04.03.2025
Panacea Biotec Consolidated December 2024 Net Sales at Rs 163.49 crore, up 8.63% Y-o-Y
28.11.2024
Panacea Biotec Consolidated September 2024 Net Sales at Rs 147.35 crore, up 3.03% Y-o-Y